SWOT Analysis for Catalyst Pharmaceuticals Inc

Add SWOT widget to your site/app

Positive Breakout Second Resistance ( LTP > R2)
High DVM Mid and Small Caps (subscription)
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Rising Momentum: Momentum Score Weekly Gainers
Companies with 10% increase in share price over three months, with rising net profit growth
High Normalized Momentum Score
Consistent Highest Return Stocks over Five Years - Nifty500
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
New 52 week high today
Relative Outperformance versus Industry over 10 Years
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
MACD crossed above zero line previous end of day
Positive Breakout (LTP > R2)
Company with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Book Value per share Improving for last 2 years
Increasing profits every quarter for the past 3 quarters
Positive Breakout (LTP > R1)
Top Gainers
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter